Outi R. Saramaki - Publications

Amplification of the 9p13.3 chromosomal region in prostate cancer.

Journal: Genes, chromosomes & cancer

Published: December 11, 2015

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.

Journal: PloS one

Published: October 30, 2015

Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma.

Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology

Published: August 24, 2015

CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.

Journal: Oncotarget

Published: December 30, 2014

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer.

Journal: Oncotarget

Published: October 27, 2014

Mapping of the chromosomal amplification 1p21-22 in bladder cancer.

Journal: BMC research notes

Published: July 15, 2014

Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers.

Journal: The Prostate

Published: February 14, 2014

Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: October 03, 2013